0001628280-24-015103.txt : 20240405 0001628280-24-015103.hdr.sgml : 20240405 20240405174451 ACCESSION NUMBER: 0001628280-24-015103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240403 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibson Christopher CENTRAL INDEX KEY: 0001856369 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40323 FILM NUMBER: 24827640 MAIL ADDRESS: STREET 1: C/O RECURSION PHARMACEUTICALS STREET 2: 41 S. RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (385) 269-0203 MAIL ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 4 1 wk-form4_1712353481.xml FORM 4 X0508 4 2024-04-03 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856369 Gibson Christopher C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 1 0 0 Chief Executive Officer 1 Class A Common Stock 2024-04-03 4 G 0 25000 0 D 1018524 D Class A Common Stock 2024-04-03 4 S 0 40000 8.84 D 978524 D Class A Common Stock 2024-04-04 4 S 0 40000 9.02 D 938524 D Class A Common Stock 2024-04-03 4 C 0 25000 0 A 25000 I by Gibson Family Trust Class A Common Stock 2024-04-03 4 S 0 25000 8.84 D 0 I by Gibson Family Trust Class A Common Stock 2024-04-04 4 C 0 25000 0 A 25000 I By LAHWRAN-3 LLC Class A Common Stock 2024-04-04 4 S 0 25000 9.02 D 0 I by LAHWRAN-3 LLC Class B Common Stock 0 2024-04-03 4 C 0 25000 0 D Class A Common Stock 25000 67875 I by Gibson Family Trust Class B Common Stock 0 2024-04-04 4 C 0 25000 0 D Class A Common Stock 25000 486000 I by LAHWRAN-3 LLC Class B Common Stock 0 Class A Common Stock 0 388000 I by LAHWRAN-4 LLC Stock Option (Right to Buy) 2.48 2030-12-30 Class A Common Stock 0 312500 D Stock Option (Right to Buy) 11.40 2032-02-04 Class A Common Stock 0 399002 D Stock Option (Right to Buy) 8.55 2033-02-01 Class A Common Stock 0 813600 D Stock Option (Right to Buy) 11.40 2022-02-04 2032-02-04 Class A Common Stock 0 5436 D Stock Option (Right to Buy) 10.09 2034-02-09 Class A Common Stock 0 666898 D This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023 Represents the conversion of Class B Common Stock into Class A Common Stock. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. /s/ Jonathan Golightly, attorney-in-fact 2024-04-05